Press releases
- Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
- Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
- Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Key statistics
On Friday, Gossamer Bio Inc (4GB:STU) closed at 0.6555, 51.46% above the 52 week low of 0.4328 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.705 |
---|---|
High | 0.705 |
Low | 0.64 |
Bid | 0.662 |
Offer | 0.7135 |
Previous close | 0.6475 |
Average volume | 0.00 |
---|---|
Shares outstanding | 226.22m |
Free float | 221.16m |
P/E (TTM) | -- |
Market cap | 167.40m USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of May 03 2024.
More ▼